Clinical Trial Update: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 study update reporting results for EP547 in patients with cholestatic pruritus due to primary biliary cholangitis or primary sclerosing cholangitis; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Sclerosing Cholangitis

Drugs mentioned

• EP547

Snippet

Sponsor: Escient Pharmaceuticals, Inc | Conditions: Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2025-07-31